---
figid: PMC3852501__pone.0081569.g006
figlink: /pmc/articles/PMC3852501/figure/pone-0081569-g006/
number: Figure 6
caption: Activations of MAPK (mitogen-activated protein kinase) and STAT (signal transducers
  and activators of transcription) negatively regulate chondrocyte proliferation and
  differentiation. MAPK signaling includes sequential stimulation of a signaling cascade
  involving RAS, RAF, MEK, and ERK. CNP binding to natriuretic peptide receptor-B
  induces the generation of the second messenger cGMP, which activates PKG and leads
  to attenuation of the MAPK pathway by inhibiting RAF activation. NF449 , A31 , and
  P3  are recently identified FGFR3 inhibitors. NF449 and A31 have inhibitory effects
  on the kinase activity of FGFR3. P3 has an affinity for extracellular domain of
  FGFR3. Meclozine attenuates ERK phosphorylation.
pmcid: PMC3852501
papertitle: Meclozine Facilitates Proliferation and Differentiation of Chondrocytes
  by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia.
reftext: Masaki Matsushita, et al. PLoS One. 2013;8(12):e81569.
pmc_ranked_result_index: '81636'
pathway_score: 0.9690138
filename: pone.0081569.g006.jpg
figtitle: Meclozine Facilitates Proliferation and Differentiation of Chondrocytes
  by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia
year: '2013'
organisms: Homo sapiens
ndex: c7d311c9-deca-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3852501__pone.0081569.g006.html
  '@type': Dataset
  description: Activations of MAPK (mitogen-activated protein kinase) and STAT (signal
    transducers and activators of transcription) negatively regulate chondrocyte proliferation
    and differentiation. MAPK signaling includes sequential stimulation of a signaling
    cascade involving RAS, RAF, MEK, and ERK. CNP binding to natriuretic peptide receptor-B
    induces the generation of the second messenger cGMP, which activates PKG and leads
    to attenuation of the MAPK pathway by inhibiting RAF activation. NF449 , A31 ,
    and P3  are recently identified FGFR3 inhibitors. NF449 and A31 have inhibitory
    effects on the kinase activity of FGFR3. P3 has an affinity for extracellular
    domain of FGFR3. Meclozine attenuates ERK phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKG1
  - MAP2K2
  - FGFR3
  - MAP2K1
  - FGF8
  - ARAF
  - RAF1
  - FGF16
  - STAT5A
  - FGF19
  - FGF17
  - FGF12
  - FGF7
  - FGF23
  - FGF9
  - FGF5
  - FGF6
  - STAT2
  - FGF18
  - STAT5B
  - FGF10
  - FGF1
  - NRAS
  - FGF21
  - FGF22
  - STAT1
  - FGF11
  - FGF2
  - FGF3
  - STAT4
  - KRAS
  - BRAF
  - STAT3
  - HRAS
  - FGF4
  - MAPK3
  - FGF20
  - FGF14
  - MAPK1
  - STAT6
  - FGF13
  - CNP
  - Meclozine
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: CNP
  symbol: CNP
  source: hgnc_symbol
  hgnc_symbol: CNP
  entrez: '1267'
chemicals:
- word: Meclozine
  source: MESH
  identifier: D008468
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
